Sena Biswas
Managing Director
AngioChem
Canada
Biography
Dr. Biswas joined VIMAC as a Venture Partner in June of 2002 and became Managing Director, Life Sciences in January, 2003. Sena Biswas previously served as a Principal at TL Ventures, a leading national venture capital firm with over $1.4 billion under management. During his tenure as one of two life science investment professionals, TL Ventures invested in several early-stage life science companies that were later listed on the NASDAQ. Dr Biswas has served as Founding CEO or President of several life science companies, most recently at Merrimack Pharmaceuticals, a network biology-based, drug discovery company spun out of MIT and Harvard. His experience also includes Aventis Pharmaceuticals, where he was Director of Business Development and Bear, Stearns & Co. where he was an Associate in the Healthcare Investment Banking Group. Representing VIMAC,
Research Interest
life sciences
